Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Debasish Sen

1PUBLICATIONS
22CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Mar 21, 2025
23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation.

Joel S Benjamin, Abigail Jarret, Shashank Bharill

Pageof 1

Frequent Collaborators

1 joint publications

Joel S Benjamin

1 joint publications

Abigail Jarret

1 joint publications

Shashank Bharill

1 joint publications

Pierre Fontanillas

1 joint publications

Shruti Yadav

1 joint publications

Dina Ayupova

1 joint publications

Danielle Kellar

1 joint publications

Susanne Tilk

1 joint publications

Clifford Hom

1 joint publications

Zahra Bahrami Dizicheh

Frequent Collaborators

1 joint publications

Joel S Benjamin

1 joint publications

Abigail Jarret

1 joint publications

Shashank Bharill

1 joint publications

Pierre Fontanillas

Top Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

3.4K
See more related videos

Top Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

3.4K
See more related videos